Company profile for ADC Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Our proprietary ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer platform. PBD dimers are very potent toxins that actively kill cancer cells and have a different mechanism of action t...
ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Our proprietary ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer platform. PBD dimers are very potent toxins that actively kill cancer cells and have a different mechanism of action than warheads commonly used in other ADCs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Route de la Corniche 3, 1066 Epalinges
Telephone
Telephone
+41 21 653 02 00
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/adc-therapeutics-reports-third-quarter-2025-financial-results-and-provides-operational-update-302608959.html

PR NEWSWIRE
10 Nov 2025

https://www.prnewswire.com/news-releases/adc-therapeutics-to-host-third-quarter-2025-financial-results-conference-call-on-november-10-2025-302600398.html

PR NEWSWIRE
03 Nov 2025

https://www.prnewswire.com/news-releases/adc-therapeutics-announces-60-million-private-placement-302581554.html

PR NEWSWIRE
13 Oct 2025

https://www.prnewswire.com/news-releases/adc-therapeutics-makes-grants-to-new-employees-under-inducement-plan-302572991.html

PR NEWSWIRE
01 Oct 2025

https://www.prnewswire.com/news-releases/adc-therapeutics-to-present-at-the-cantor-global-healthcare-conference-2025-302539375.html

PR NEWSWIRE
27 Aug 2025

https://www.prnewswire.com/news-releases/adc-therapeutics-reports-second-quarter-2025-financial-results-and-provides-operational-update-302526777.html

PR NEWSWIRE
12 Aug 2025

ABOUT THIS PAGE

Contact ADC Therapeutics and get a quotation

ADC Therapeutics is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of ADCT-701 DRUG SUBSTANCE bulk with DMF offered by ADC Therapeutics

Find a price of PL1601 DRUG LINKER bulk with DMF offered by ADC Therapeutics

Find a price of ADCT-701 DRUG PRODUCT bulk with DMF offered by ADC Therapeutics

Find a price of HUBA-1-3D-GAINACN3 MAB bulk with DMF offered by ADC Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty